First signs of reverse cardiac remodeling following one-month, low dose add-on sacubitril-valsartan therapy in patients with advanced systolic heart failure (W. Sacharczuk, R. . Dankowski, A. Sowińska, A. Baszko, & A. Szyszka , Trans.). (2022). Journal of Medical Science, 91(1), e606. https://doi.org/10.20883/medical.e606